These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27875644)

  • 21. The indispensable role of professional judgment in genomic medicine.
    McGuire AL; McCullough LB; Evans JP
    JAMA; 2013 Apr; 309(14):1465-6. PubMed ID: 23571582
    [No Abstract]   [Full Text] [Related]  

  • 22. How Can Law Support Development of Genomics and Precision Medicine to Advance Health Equity and Reduce Disparities?
    Wolf SM; Bonham VL; Bruce MA
    Ethn Dis; 2019; 29(Suppl 3):623-628. PubMed ID: 31889767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyped biomedical science or uncritical reporting? Press coverage of genomics (1992-2001) in Québec.
    Racine E; Gareau I; Doucet H; Laudy D; Jobin G; Schraedley-Desmond P
    Soc Sci Med; 2006 Mar; 62(5):1278-90. PubMed ID: 16174544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The elusive ideal of inclusiveness: lessons from a worldwide survey of neurologists on the ethical issues raised by whole-genome sequencing.
    Hurlimann T; Jaitovich Groisman I; Godard B
    BMC Med Ethics; 2017 Apr; 18(1):28. PubMed ID: 28399922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patient privacy in the genomic era.
    Raisaro JL; Ayday E; Hubaux JP
    Praxis (Bern 1994); 2014 May; 103(10):579-86. PubMed ID: 24800770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Should we sequence everyone's genome? Yes.
    Burn J
    BMJ; 2013 May; 346():f3133. PubMed ID: 23694691
    [No Abstract]   [Full Text] [Related]  

  • 27. Beyond inclusion: Enacting team equity in precision medicine research.
    Jeske M; Vasquez E; Fullerton SM; Saperstein A; Bentz M; Foti N; Shim JK; Lee SS
    PLoS One; 2022; 17(2):e0263750. PubMed ID: 35130331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [ETHICS, MORALS AND SOCIETY IN PERSONALIZED MEDICINE].
    Flugelman A
    Harefuah; 2015 Sep; 154(9):599-603, 606. PubMed ID: 26665754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ethics Hype?
    Caulfield T
    Hastings Cent Rep; 2016 Sep; 46(5):13-6. PubMed ID: 27649824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is Real-Time ELSI Realistic?
    Conley JM; Prince AER; Davis AM; Cadigan J; Lazaro-Munoz G
    AJOB Empir Bioeth; 2020; 11(2):134-144. PubMed ID: 32040382
    [No Abstract]   [Full Text] [Related]  

  • 31. Should Electronic Health Record-Derived Social and Behavioral Data Be Used in Precision Medicine Research?
    Hollister B; Bonham VL
    AMA J Ethics; 2018 Sep; 20(9):E873-880. PubMed ID: 30242819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The interplay of ethics and genetic technologies in balancing the social valuation of the human genome in UNESCO declarations.
    Gaydarska H; Takashima K; Shahrier S; Raz A; Minari J
    Eur J Hum Genet; 2024 Jun; 32(6):725-730. PubMed ID: 38355962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Precision medicine ethics: selected issues and developments in next-generation sequencing, clinical oncology, and ethics.
    Fiore RN; Goodman KW
    Curr Opin Oncol; 2016 Jan; 28(1):83-7. PubMed ID: 26569425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Translating genomics for precision cancer medicine.
    Roychowdhury S; Chinnaiyan AM
    Annu Rev Genomics Hum Genet; 2014; 15():395-415. PubMed ID: 25184532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Return of research results from pharmacogenomic versus disease susceptibility studies: what's drugs got to do with it?
    Dressler LG
    Pharmacogenomics; 2012 Jun; 13(8):935-49. PubMed ID: 22676197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Difficulties and challenges in the development of precision medicine.
    Liu X; Luo X; Jiang C; Zhao H
    Clin Genet; 2019 May; 95(5):569-574. PubMed ID: 30653655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A pragmatic consideration of ethical issues relating to personal genomics.
    Hsu AR; Mountain JL; Wojcicki A; Avey L
    Am J Bioeth; 2009; 9(6-7):1-2. PubMed ID: 19998098
    [No Abstract]   [Full Text] [Related]  

  • 38. Following the giant's paces-governance issues and bioethical reflections in China.
    Wang Z; Zhang D; Ng VH; Lie R; Zhai X
    BMC Med Ethics; 2014 Oct; 15():79. PubMed ID: 25361573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Transition and problems of ethical guidelines for medical research in Japan].
    Kosugi S
    Masui; 2011 Nov; 60 Suppl():S37-44. PubMed ID: 22458021
    [No Abstract]   [Full Text] [Related]  

  • 40. Genetics, neuroscience, and biotechnology.
    Lappé M
    Hastings Cent Rep; 1990; 20(6):21-2. PubMed ID: 2283282
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.